Dexmedetomidine and Remifentanil in NORA

PHASE4CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

December 17, 2022

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Comparison of the Effects of Remifentanil and Dexmedetomidine
Interventions
DRUG

Dexmedetomidine

Group DP received 0.5 mcg/kg of dexmedetomidine IV for 30 seconds, then dexmedetomidine infusion was started at 0.1-0.7 mcg/kg/h. Propofol 1 mg/kg was administered after waiting for 5 minutes for adequate sedation to develop due to dexmedetomidine's delayed onset of action.

DRUG

Remifentanil

Group RP received remifentanil 0.1 mcg/kg intravenously for 30 seconds, then remifentanil infusion was started at 0.01-0.1 mcg/kg/min. After waiting 2 minutes to develop a sufficient sedation level, 1 mg/kg of propofol was given.

Trial Locations (1)

06490

Baskent University Ankara Hospital, Ankara

All Listed Sponsors
lead

Baskent University Ankara Hospital

OTHER